Innovative Biomaterial Demonstrates Potential to Reverse Heart Aging
A new hybrid biomaterial developed by researchers shows promise in reversing age-related changes in heart tissue by targeting the extracellular matrix, opening new possibilities for regenerative therapies.
Recent advancements in regenerative medicine have revealed promising insights into combating cardiac aging. Researchers from the National University of Singapore have developed a pioneering lab-grown hybrid biomaterial called DECIPHER, which closely mimics the heart's extracellular matrix (ECM) to study its role in aging. The ECM—comprising proteins and biochemical signals—surrounds heart cells, providing structural support and guiding cellular functions. As the heart ages, the ECM becomes stiffer and undergoes compositional changes that negatively impact cell health, leading to scarring and reduced cardiac performance.
The team, led by Assistant Professor Jennifer Young, utilized DECIPHER to independently control the physical stiffness and biochemical cues of the ECM, allowing for precise analysis of their effects on heart cells. Experiments demonstrated that when aged heart cells were placed on scaffolds mimicking youthful biochemical signals, they reverted to a healthier, more functional state—even if the scaffold remained stiff. Conversely, young cells exhibited dysfunction when exposed to aged ECM cues, regardless of scaffold stiffness.
This research highlights that biochemical signals in the ECM have a more significant impact on cell aging than physical stiffness alone. The findings suggest that restoring youthful biochemical environments could be a viable strategy to reverse some age-related cardiac damage. Furthermore, the DECIPHER platform offers potential to investigate other tissues affected by aging, as changes in tissue stiffness and biochemical composition are common in various age-related diseases like fibrosis and cancer.
While still in the experimental phase, this groundbreaking approach opens new avenues for therapies focused on modifying the tissue environment to preserve or restore heart function during aging. The methodology could also be adapted for broader biomedical research, targeting tissue-specific aging and disease processes across the body.
Source: https://medicalxpress.com/news/2025-06-hybrid-biomaterial-aging-heart-reversed.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Study Reveals Earned Sick Leave Alone Is Insufficient for Uninsured Workers' Wellbeing
New research shows that earned sick leave improves workplace health reporting but is not enough for uninsured or vulnerable workers. Broader health policies are essential to protect all employees.
New Insights into How Acetaminophen Alleviates Pain: A Breakthrough Study
A groundbreaking study reveals that acetaminophen (Tylenol) works not only in the brain but also directly on peripheral nerves by producing a compound that blocks pain signals, opening new avenues for safer pain relief medications.
How Breast Cancer Medications Target Genomic Damage in Tumors
Recent research reveals how breast cancer drugs like PARP inhibitors create DNA fractures in tumors, leveraging genetic weaknesses to improve therapy effectiveness.
New Insights into the DJ-1 Gene’s Role in Parkinson's Disease
New research uncovers the molecular mechanism by which the DJ-1 gene protects cells in Parkinson's disease, highlighting its role in detoxifying harmful metabolites. This breakthrough enhances our understanding of hereditary Parkinson's and offers potential targets for future therapies.